BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barcellini W, Giannotta JA, Fattizzo B. Autoimmune Complications in Hematologic Neoplasms. Cancers (Basel) 2021;13:1532. [PMID: 33810369 DOI: 10.3390/cancers13071532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Barcellini W, Fattizzo B. Immune Phenomena in Myeloid Neoplasms: An "Egg or Chicken" Question. Front Immunol 2021;12:751630. [PMID: 34659257 DOI: 10.3389/fimmu.2021.751630] [Reference Citation Analysis]
2 Fattizzo B, Bellani V, Pasquale R, Giannotta JA, Barcellini W. Large Granular Lymphocyte Expansion in Myeloid Diseases and Bone Marrow Failure Syndromes: Whoever Seeks Finds. Front Oncol 2021;11:748610. [PMID: 34660312 DOI: 10.3389/fonc.2021.748610] [Reference Citation Analysis]
3 Radic M, Neeli I, Marion T. Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus. Expert Opin Biol Ther 2022;:1-9. [PMID: 35089116 DOI: 10.1080/14712598.2022.2026921] [Reference Citation Analysis]
4 Rosário-Ferreira N, Guimarães V, Costa VS, Moreira IS. SicknessMiner: a deep-learning-driven text-mining tool to abridge disease-disease associations. BMC Bioinformatics 2021;22:482. [PMID: 34607568 DOI: 10.1186/s12859-021-04397-w] [Reference Citation Analysis]
5 Fattizzo B, Da Vià MC, Kulasekararaj AG. Editorial: Immunologic Mechanisms of Myeloid Neoplasms. Front Oncol 2022;12:949633. [DOI: 10.3389/fonc.2022.949633] [Reference Citation Analysis]
6 Asako M, Matsunaga H, Oka K, Ueda S. Schnitzler Syndrome after COVID-19 Vaccination. Intern Med 2022. [PMID: 35650133 DOI: 10.2169/internalmedicine.9598-22] [Reference Citation Analysis]
7 Fattizzo B, Rampi N, Barcellini W. Hematological and Extra-Hematological Autoimmune Complications after Checkpoint Inhibitors. Pharmaceuticals 2022;15:557. [DOI: 10.3390/ph15050557] [Reference Citation Analysis]
8 Guerra JD, Gowarty J, Buess J, Mason J, Halka K, Reikvam H. A Case of Acquired Hemophilia A in a Patient with Exposure to COVID-19. Case Reports in Hematology 2022;2022:1-3. [DOI: 10.1155/2022/9494249] [Reference Citation Analysis]
9 Sobas M, Podolak-Dawidziak M, Lewandowski K, Bator M, Wróbel T. Primary Immune Thrombocytopenia and Essential Thrombocythemia: So Different and yet Somehow Similar-Cases Series and a Review of the Literature. Int J Mol Sci 2021;22:10918. [PMID: 34681577 DOI: 10.3390/ijms222010918] [Reference Citation Analysis]
10 Jobson D, McCormack CJ, Mar V, Tam C, Henderson MA. Impact of chronic lymphocytic leukaemia on melanoma outcomes: A retrospective case-control study. Br J Haematol 2022. [PMID: 35286715 DOI: 10.1111/bjh.18090] [Reference Citation Analysis]
11 Fabozzi F, Mastronuzzi A, Ceglie G, Masetti R, Leardini D. GATA 2 Deficiency: Focus on Immune System Impairment. Front Immunol 2022;13:865773. [DOI: 10.3389/fimmu.2022.865773] [Reference Citation Analysis]
12 Albiol N, Moreno C. Autoimmune Cytopenia in CLL: Prognosis and Management in the Era of Targeted Therapies. Cancer J 2021;27:286-96. [PMID: 34398555 DOI: 10.1097/PPO.0000000000000537] [Reference Citation Analysis]
13 Du M, Huang L, Kou H, Li C, Hu Y, Mei H. Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma. Front Immunol 2022;13:898341. [DOI: 10.3389/fimmu.2022.898341] [Reference Citation Analysis]
14 Fattizzo B, Levati GV, Giannotta JA, Cassanello G, Cro LM, Zaninoni A, Barbieri M, Croci GA, Revelli N, Barcellini W. Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience. Front Oncol 2022;12:795955. [PMID: 35392224 DOI: 10.3389/fonc.2022.795955] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Fillitz M, Dixer B, Keil F. Practical considerations for the management of immune thrombocytopenic purpura. Memo 2021;:1-5. [PMID: 34691269 DOI: 10.1007/s12254-021-00771-9] [Reference Citation Analysis]
16 Autore F, Pasquale R, Innocenti I, Fresa A, Sora' F, Laurenti L. Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review. Cancers (Basel) 2021;13:5804. [PMID: 34830959 DOI: 10.3390/cancers13225804] [Reference Citation Analysis]
17 Fattizzo B, Barcellini W. Autoimmune hemolytic anemia: causes and consequences. Expert Rev Clin Immunol 2022;:1-15. [PMID: 35702053 DOI: 10.1080/1744666X.2022.2089115] [Reference Citation Analysis]